Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Phase 2b Open-Label Multi-Center Study Assessing the Immunological Persistence of Antibodies at Approximately 2 Years After the Last Meningococcal Vaccination in Study V102_15 (NCT02212457) and the
Brief Summary: The purpose of this study is to compare the effectiveness of 2 (given at 0, 2 months) or 3 (given at 0, 2, 6 months) doses of the GSK MenABCWY vaccine administered to healthy adolescents in study V102_15 (NCT02212457), against a panel of randomly selected U.S. N. meningitidis serogroup B invasive disease strains at 24 months after the last meningococcal vaccination in V102_15 (NCT02212457) and response to a booster dose.